Patents Assigned to ICEUTICA PTY LTD.
-
Publication number: 20210401753Abstract: A method for improving the dissolution profile of a biologically active materialType: ApplicationFiled: September 7, 2021Publication date: December 30, 2021Applicant: iCeutica Pty Ltd.Inventors: Aaron Dodd, Felix Meiser, Marck NORRET, Adrian Russell, H. William Bosch
-
Patent number: 11103456Abstract: A method for producing a composition comprising nanoparticles of a biologically active compound.Type: GrantFiled: June 22, 2018Date of Patent: August 31, 2021Assignee: iCeutica Pty Ltd.Inventors: Raffaele Cammarano, Felix Meiser, Almar Postma, Frank Caruso
-
Publication number: 20200375903Abstract: A method for improving the dissolution profile of a biologically active materialType: ApplicationFiled: December 17, 2019Publication date: December 3, 2020Applicant: iCeutica Pty Ltd.Inventors: Aaron Dodd, Felix Meiser, Marck NORRET, Adrian Russell, H. William Bosch
-
Publication number: 20200360294Abstract: The present invention relates to improved therapeutically active nanocomposite microstructure compositions, including nanoparticle compositions and nanoparticle preparations. Preferred embodiments include nanoparticle compositions comprising nanoparticles of a therapeutically active agent dispersed in a carrier matrix. The invention also relates to a method for preparing said compositions and preparations using solid-state mechanochemical synthesis. Further, it relates to therapeutic products produced using said compositions and to methods of treatment using the compositions.Type: ApplicationFiled: August 4, 2020Publication date: November 19, 2020Applicant: iCeutica Pty Ltd.Inventors: Trevor Payne, Felix Meiser, Almar Postma, Raffaele Cammarano, James Williams, Paul McCormick, Aaron Dodd, Frank Caruso
-
Publication number: 20200316546Abstract: The present invention relates to methods for producing particles of a biologically active material using dry milling processes as well as compositions comprising such materials, medicaments produced using said biologically active materials in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of said biologically active materials administered by way of said medicaments.Type: ApplicationFiled: January 27, 2020Publication date: October 8, 2020Applicant: iCeutica Pty Ltd.Inventors: Aaron Dodd, Felix Meiser, Marck Norret, Adrian Russell, H. William Bosch
-
Patent number: 10172828Abstract: The present invention relates to methods for producing particles of indomethacin using dry milling processes as well as compositions comprising indomethacin, medicaments produced using indomethacin in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of indomethacin administered by way of said medicaments.Type: GrantFiled: December 22, 2017Date of Patent: January 8, 2019Assignee: iCeutica Pty Ltd.Inventors: Aaron Dodd, Felix Meiser, Marck Norret, Adrian Russell, H. William Bosch
-
Publication number: 20180243707Abstract: The present invention relates to methods for producing particles of a biologically active material using dry milling processes as well as compositions comprising such materials, medicaments produced using said biologically active materials in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of said biologically active materials administered by way of said medicaments.Type: ApplicationFiled: February 23, 2018Publication date: August 30, 2018Applicant: iCeutica Pty Ltd.Inventors: Aaron Dodd, Felix Meiser, Marck Norret, Adrian Russell, H. William Bosch
-
Patent number: 10022303Abstract: Methods for making inhalable composite particles comprising a pharmaceutically-active agent, the method comprising: a) providing composite particles comprising a millable grinding matrix and a solid pharmaceutically-active agent, wherein the pharmaceutically-active agent has an median particle size on a volume average basis between 50 nm and 3 ?m; and b) milling the composite particles in a mill without milling bodies for a time period sufficient to produce inhalable composite particles having a mass median aerodynamic diameter between 1 ?m and 20 ?m are described.Type: GrantFiled: February 28, 2013Date of Patent: July 17, 2018Assignee: iCeutica Pty Ltd.Inventors: H. William Bosch, Matthew Callahan, Felix Meiser, Marck Norret, Adrian Russell
-
Publication number: 20180169028Abstract: The present invention relates to improved therapeutically active nanocomposite microstructure compositions, including nanoparticle compositions and nanoparticle preparations. Preferred embodiments include nanoparticle compositions comprising nanoparticles of a therapeutically active agent dispersed in a carrier matrix. The invention also relates to a method for preparing said compositions and preparations using solid-state mechanochemical synthesis. Further, it relates to therapeutic products produced using said compositions and to methods of treatment using the compositions.Type: ApplicationFiled: January 8, 2018Publication date: June 21, 2018Applicant: iCeutica Pty Ltd.Inventors: Trevor Payne, Felix Meiser, Almar Postma, Raffaele Cammarano, James Williams, Paul McCormick, Aaron Dodd, Frank Caruso
-
Publication number: 20180169018Abstract: A method for improving the dissolution profile of a biologically active materialType: ApplicationFiled: January 19, 2018Publication date: June 21, 2018Applicant: iCeutica Pty Ltd.Inventors: Aaron Dodd, Felix Meiser, Marck NORRET, Adrian Russell, H. William Bosch
-
Patent number: 9849111Abstract: The present invention relates to methods for producing particles of indomethacin using dry milling processes as well as compositions comprising indomethacin, medicaments produced using indomethacin in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of indomethacin administered by way of said medicaments.Type: GrantFiled: December 19, 2016Date of Patent: December 26, 2017Assignee: iCeutica Pty Ltd.Inventors: Aaron Dodd, Felix Meiser, Marck Norret, Adrian Russell, H. William Bosch
-
Patent number: 9808468Abstract: Unit dosage forms of meloxicam containing either 5 mg or 10 mg of meloxicam that provide effective pain relief and have desirable pharmacokinetic properties are described. The unit dosage forms can provide pain relief when a single unit dose is administered to a patient and useful for treating pain such as osteoarthritis pain at a relatively low systemic exposure to meloxicam.Type: GrantFiled: May 15, 2017Date of Patent: November 7, 2017Assignee: iCeutica Pty Ltd.Inventor: H. William Bosch
-
Patent number: 9649318Abstract: Unit dosage forms of meloxicam containing either 5 mg or 10 mg of meloxicam that provide effective pain relief and have desirable pharmacokinetic properties are described. The unit dosage forms can provide pain relief when a single unit dose is administered to a patient and useful for treating pain such as osteoarthritis pain at a relatively low systemic exposure to meloxicam.Type: GrantFiled: December 18, 2015Date of Patent: May 16, 2017Assignee: iCeutica Pty Ltd.Inventor: H. William Bosch
-
Patent number: 9526734Abstract: Unit dosage forms of meloxicam containing either 5 mg or 10 mg of meloxicam that provide effective pain relief and have desirable pharmacokinetic properties are described. The unit dosage forms can provide pain relief when a single unit dose is administered to a patient and useful for treating pain such as osteoarthritis pain at a relatively low systemic exposure to meloxicam.Type: GrantFiled: March 31, 2015Date of Patent: December 27, 2016Assignee: iCeutica Pty Ltd.Inventor: H. William Bosch
-
Patent number: 9522135Abstract: The present invention relates to methods for producing particles of indomethacin using dry milling processes as well as compositions comprising indomethacin, medicaments produced using indomethacin in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of indomethacin administered by way of said medicaments.Type: GrantFiled: July 27, 2015Date of Patent: December 20, 2016Assignee: iCeutica Pty Ltd.Inventors: Aaron Dodd, Felix Meiser, Marck Norret, Adrian Russell, H. William Bosch
-
Patent number: 9186328Abstract: The present invention relates to methods for producing particles of diclofenac using dry milling processes as well as compositions comprising diclofenac, medicaments produced using diclofenac in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of diclofenac administered by way of said medicaments.Type: GrantFiled: February 13, 2015Date of Patent: November 17, 2015Assignee: iCeutica Pty Ltd.Inventors: Aaron Dodd, Felix Meiser, Marck Norret, Adrian Russell, H William Bosch
-
Patent number: 9180096Abstract: The present invention relates to methods for producing particles of diclofenac using dry milling processes as well as compositions comprising diclofenac, medicaments produced using diclofenac in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of diclofenac administered by way of said medicaments.Type: GrantFiled: February 12, 2015Date of Patent: November 10, 2015Assignee: iCeutica Pty Ltd.Inventors: Aaron Dodd, Felix Meiser, Marck Norret, Adrian Russell, H William Bosch
-
Patent number: 9180095Abstract: The present invention relates to methods for producing particles of diclofenac using dry milling processes as well as compositions comprising diclofenac, medicaments produced using diclofenac in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of diclofenac administered by way of said medicaments.Type: GrantFiled: February 13, 2015Date of Patent: November 10, 2015Assignee: iCeutica Pty Ltd.Inventors: Aaron Dodd, Felix Meiser, Marck Norret, Adrian Russell, H William Bosch
-
Patent number: 9173854Abstract: The present invention relates to methods for producing particles of diclofenac using dry milling processes as well as compositions comprising diclofenac, medicaments produced using diclofenac in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of diclofenac administered by way of said medicaments.Type: GrantFiled: February 13, 2015Date of Patent: November 3, 2015Assignee: iCeutica Pty Ltd.Inventors: Aaron Dodd, Felix Meiser, Marck Norret, Adrian Russell, H William Bosch
-
Patent number: 9095496Abstract: The present invention relates to methods for producing particles of indomethacin using dry milling processes as well as compositions comprising indomethacin, medicaments produced using indomethacin in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of indomethacin administered by way of said medicaments.Type: GrantFiled: January 6, 2014Date of Patent: August 4, 2015Assignee: iCeutica Pty Ltd.Inventors: Aaron Dodd, Felix Meiser, Marck Norret, Adrian Russell, H. William Bosch